VYCO Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of 0.97% compared to Vycor Medical, Inc.'s net margin of --. Vycor Medical, Inc.'s return on equity of -- beat Picard Medical's return on equity of --.

Vycor Medical, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Vycor Medical, Inc. has higher upside potential than Picard Medical, analysts believe Vycor Medical, Inc. is more attractive than Picard Medical.

Vycor Medical, Inc. has a beta of -0.389, which suggesting that the stock is 138.922% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Vycor Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vycor Medical, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

Vycor Medical, Inc. quarterly revenues are $513.8K, which are larger than Picard Medical quarterly revenues of --. Vycor Medical, Inc.'s net income of $5K is higher than Picard Medical's net income of --. Notably, Vycor Medical, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vycor Medical, Inc. is 2.92x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of 0.97% compared to Vycor Medical, Inc.'s net margin of -862.39%. Vycor Medical, Inc.'s return on equity of -- beat VolitionRX Ltd.'s return on equity of --.

Vycor Medical, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 866.54%. Given that VolitionRX Ltd. has higher upside potential than Vycor Medical, Inc., analysts believe VolitionRX Ltd. is more attractive than Vycor Medical, Inc..

Vycor Medical, Inc. has a beta of -0.389, which suggesting that the stock is 138.922% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Vycor Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vycor Medical, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Vycor Medical, Inc. quarterly revenues are $513.8K, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Vycor Medical, Inc.'s net income of $5K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Vycor Medical, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vycor Medical, Inc. is 2.92x versus 18.43x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of 0.97% compared to Vycor Medical, Inc.'s net margin of -1037.17%. Vycor Medical, Inc.'s return on equity of -- beat Catheter Precision, Inc.'s return on equity of -192.05%.

Vycor Medical, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1405%. Given that Catheter Precision, Inc. has higher upside potential than Vycor Medical, Inc., analysts believe Catheter Precision, Inc. is more attractive than Vycor Medical, Inc..

Vycor Medical, Inc. has a beta of -0.389, which suggesting that the stock is 138.922% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Vycor Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vycor Medical, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Vycor Medical, Inc. quarterly revenues are $513.8K, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Vycor Medical, Inc.'s net income of $5K is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Vycor Medical, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vycor Medical, Inc. is 2.92x versus 11.87x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of 0.97% compared to Vycor Medical, Inc.'s net margin of 3.93%. Vycor Medical, Inc.'s return on equity of -- beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Vycor Medical, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 106.9%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Vycor Medical, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Vycor Medical, Inc..

Vycor Medical, Inc. has a beta of -0.389, which suggesting that the stock is 138.922% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Vycor Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vycor Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Vycor Medical, Inc. quarterly revenues are $513.8K, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Vycor Medical, Inc.'s net income of $5K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Vycor Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 71.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vycor Medical, Inc. is 2.92x versus 0.79x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.